IBDEI2TI ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47304,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,47305,0)
 ;;=C81.91^^209^2346^220
 ;;^UTILITY(U,$J,358.3,47305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47305,1,3,0)
 ;;=3^Hodgkin Lymphoma,Head/Face/Neck Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47305,1,4,0)
 ;;=4^C81.91
 ;;^UTILITY(U,$J,358.3,47305,2)
 ;;=^5001452
 ;;^UTILITY(U,$J,358.3,47306,0)
 ;;=C81.92^^209^2346^228
 ;;^UTILITY(U,$J,358.3,47306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47306,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrathoracic Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47306,1,4,0)
 ;;=4^C81.92
 ;;^UTILITY(U,$J,358.3,47306,2)
 ;;=^5001453
 ;;^UTILITY(U,$J,358.3,47307,0)
 ;;=C81.93^^209^2346^224
 ;;^UTILITY(U,$J,358.3,47307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47307,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intra-Abdominal Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47307,1,4,0)
 ;;=4^C81.93
 ;;^UTILITY(U,$J,358.3,47307,2)
 ;;=^5001454
 ;;^UTILITY(U,$J,358.3,47308,0)
 ;;=C81.94^^209^2346^216
 ;;^UTILITY(U,$J,358.3,47308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47308,1,3,0)
 ;;=3^Hodgkin Lymphoma,Axilla/Upper Limb Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47308,1,4,0)
 ;;=4^C81.94
 ;;^UTILITY(U,$J,358.3,47308,2)
 ;;=^5001455
 ;;^UTILITY(U,$J,358.3,47309,0)
 ;;=C81.95^^209^2346^222
 ;;^UTILITY(U,$J,358.3,47309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47309,1,3,0)
 ;;=3^Hodgkin Lymphoma,Ing Region/Lower Limb Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47309,1,4,0)
 ;;=4^C81.95
 ;;^UTILITY(U,$J,358.3,47309,2)
 ;;=^5001456
 ;;^UTILITY(U,$J,358.3,47310,0)
 ;;=C81.96^^209^2346^226
 ;;^UTILITY(U,$J,358.3,47310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47310,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrapelvic Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47310,1,4,0)
 ;;=4^C81.96
 ;;^UTILITY(U,$J,358.3,47310,2)
 ;;=^5001457
 ;;^UTILITY(U,$J,358.3,47311,0)
 ;;=C81.97^^209^2346^232
 ;;^UTILITY(U,$J,358.3,47311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47311,1,3,0)
 ;;=3^Hodgkin Lymphoma,Spleen,Unspec
 ;;^UTILITY(U,$J,358.3,47311,1,4,0)
 ;;=4^C81.97
 ;;^UTILITY(U,$J,358.3,47311,2)
 ;;=^5001458
 ;;^UTILITY(U,$J,358.3,47312,0)
 ;;=C81.98^^209^2346^230
 ;;^UTILITY(U,$J,358.3,47312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47312,1,3,0)
 ;;=3^Hodgkin Lymphoma,Mult Site Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,47312,1,4,0)
 ;;=4^C81.98
 ;;^UTILITY(U,$J,358.3,47312,2)
 ;;=^5001459
 ;;^UTILITY(U,$J,358.3,47313,0)
 ;;=C81.99^^209^2346^218
 ;;^UTILITY(U,$J,358.3,47313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47313,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites,Unspec
 ;;^UTILITY(U,$J,358.3,47313,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,47313,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,47314,0)
 ;;=C82.00^^209^2346^149
 ;;^UTILITY(U,$J,358.3,47314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47314,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,47314,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,47314,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,47315,0)
 ;;=C82.01^^209^2346^142
 ;;^UTILITY(U,$J,358.3,47315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47315,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47315,1,4,0)
 ;;=4^C82.01
 ;;^UTILITY(U,$J,358.3,47315,2)
 ;;=^5001462
 ;;^UTILITY(U,$J,358.3,47316,0)
 ;;=C82.02^^209^2346^146
 ;;^UTILITY(U,$J,358.3,47316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47316,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47316,1,4,0)
 ;;=4^C82.02
 ;;^UTILITY(U,$J,358.3,47316,2)
 ;;=^5001463
 ;;^UTILITY(U,$J,358.3,47317,0)
 ;;=C82.03^^209^2346^144
